PL322529A1 - Complex compositions containing benazeoprile or benazeprilate and valsartan - Google Patents
Complex compositions containing benazeoprile or benazeprilate and valsartanInfo
- Publication number
- PL322529A1 PL322529A1 PL96322529A PL32252996A PL322529A1 PL 322529 A1 PL322529 A1 PL 322529A1 PL 96322529 A PL96322529 A PL 96322529A PL 32252996 A PL32252996 A PL 32252996A PL 322529 A1 PL322529 A1 PL 322529A1
- Authority
- PL
- Poland
- Prior art keywords
- benazeoprile
- benazeprilate
- valsartan
- compositions containing
- complex compositions
- Prior art date
Links
- 239000004072 C09CA03 - Valsartan Substances 0.000 title 1
- MADRIHWFJGRSBP-ROUUACIJSA-N benazeprilat Chemical compound C([C@H](N[C@H]1CCC2=CC=CC=C2N(C1=O)CC(=O)O)C(O)=O)CC1=CC=CC=C1 MADRIHWFJGRSBP-ROUUACIJSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title 1
- 229960004699 valsartan Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH101295 | 1995-04-07 | ||
| PCT/EP1996/001440 WO1996031234A1 (en) | 1995-04-07 | 1996-04-02 | Combination compositions containing benazepril or benazeprilat and valsartan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL322529A1 true PL322529A1 (en) | 1998-02-02 |
Family
ID=4200393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96322529A PL322529A1 (en) | 1995-04-07 | 1996-04-02 | Complex compositions containing benazeoprile or benazeprilate and valsartan |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0820302A1 (cs) |
| JP (1) | JPH11503139A (cs) |
| KR (1) | KR19980703647A (cs) |
| CN (1) | CN1181019A (cs) |
| AU (1) | AU5399096A (cs) |
| BR (1) | BR9604818A (cs) |
| CA (1) | CA2214143A1 (cs) |
| CZ (1) | CZ313897A3 (cs) |
| HU (1) | HUP9801593A2 (cs) |
| MX (1) | MX9707683A (cs) |
| NO (1) | NO974400D0 (cs) |
| PL (1) | PL322529A1 (cs) |
| SK (1) | SK133897A3 (cs) |
| TR (1) | TR199701121T1 (cs) |
| WO (1) | WO1996031234A1 (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997002032A1 (en) * | 1995-06-30 | 1997-01-23 | Merck & Co., Inc. | Method of treating renal disease using an ace inhibitor and an aii antagonist |
| CN101011390A (zh) | 1999-01-26 | 2007-08-08 | 诺瓦提斯公司 | 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用 |
| RU2298418C2 (ru) * | 2000-04-12 | 2007-05-10 | Новартис Аг | Комбинация по меньшей мере двух соединений, выбранных из групп антагонистов at1-рецептора или ингибиторов асе (ангиотензинпревращающий фермент), или ингибиторов hmg-coa-редуктазы (бета-гидрокси-бета-метилглутарил-кофермент-а-редуктаза) |
| ES2309090T3 (es) | 2000-07-19 | 2008-12-16 | Novartis Ag | Sales de valsartan. |
| HRP20030124A2 (en) * | 2000-08-22 | 2005-02-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg. | Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
| AU2581601A (en) * | 2000-12-18 | 2002-07-01 | Novartis Ag | Therapeutic combination of amlodipine and benazepril |
| US6869970B2 (en) * | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
| CN1465712A (zh) * | 2002-07-05 | 2004-01-07 | 安徽省生物医学研究所 | 一种预测acei类降压药药效的试剂盒、方法、软件和复方药 |
| AU2003268219B2 (en) * | 2002-08-28 | 2009-09-24 | Barnes-Jewish Hospital | Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| CN101869710A (zh) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | 降压药物组合物 |
| US8871795B2 (en) | 2009-05-20 | 2014-10-28 | Boehringer Ingleheim Vetmedica Gmbh | Pharmaceutical oral telmisartan solution |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| CN113144204A (zh) * | 2014-01-31 | 2021-07-23 | 詹森药业有限公司 | 用于治疗和预防肾病和脂肪肝病的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227346B1 (en) * | 1990-05-11 | 2011-04-28 | Pfizer | Process for producing synergetic pharmaceutical composition |
| EP0629408A1 (en) * | 1993-06-16 | 1994-12-21 | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET | Combination of angiotensin converting enzyme inhibitors and AII antagonists |
-
1996
- 1996-04-02 JP JP8529972A patent/JPH11503139A/ja active Pending
- 1996-04-02 SK SK1338-97A patent/SK133897A3/sk unknown
- 1996-04-02 CN CN96193111A patent/CN1181019A/zh active Pending
- 1996-04-02 BR BR9604818A patent/BR9604818A/pt not_active Application Discontinuation
- 1996-04-02 CZ CZ973138A patent/CZ313897A3/cs unknown
- 1996-04-02 WO PCT/EP1996/001440 patent/WO1996031234A1/en not_active Application Discontinuation
- 1996-04-02 TR TR97/01121T patent/TR199701121T1/xx unknown
- 1996-04-02 EP EP96910948A patent/EP0820302A1/en not_active Withdrawn
- 1996-04-02 CA CA002214143A patent/CA2214143A1/en not_active Abandoned
- 1996-04-02 HU HU9801593A patent/HUP9801593A2/hu unknown
- 1996-04-02 PL PL96322529A patent/PL322529A1/xx unknown
- 1996-04-02 KR KR1019970707046A patent/KR19980703647A/ko not_active Withdrawn
- 1996-04-02 MX MX9707683A patent/MX9707683A/es unknown
- 1996-04-02 AU AU53990/96A patent/AU5399096A/en not_active Abandoned
-
1997
- 1997-09-23 NO NO974400A patent/NO974400D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9604818A (pt) | 1998-06-09 |
| MX9707683A (es) | 1997-12-31 |
| HUP9801593A2 (hu) | 1999-01-28 |
| JPH11503139A (ja) | 1999-03-23 |
| CZ313897A3 (cs) | 1998-01-14 |
| SK133897A3 (en) | 1998-02-04 |
| NO974400L (no) | 1997-09-23 |
| NO974400D0 (no) | 1997-09-23 |
| TR199701121T1 (xx) | 1998-03-21 |
| AU5399096A (en) | 1996-10-23 |
| CN1181019A (zh) | 1998-05-06 |
| CA2214143A1 (en) | 1996-10-10 |
| WO1996031234A1 (en) | 1996-10-10 |
| EP0820302A1 (en) | 1998-01-28 |
| KR19980703647A (ko) | 1998-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2298422B (en) | Compounds and their use | |
| IL118825A0 (en) | 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use | |
| IL119864A0 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use | |
| ZA965857B (en) | Cable-sheathing composition | |
| IL117859A0 (en) | Isothiazolones and their uses | |
| IL117294A (en) | Organosilicon compounds and compositions containing them | |
| SG52651A1 (en) | Composition | |
| GB9525812D0 (en) | Composition and use | |
| PL322571A1 (en) | Deodoising composition | |
| IL122717A0 (en) | Compounds and pharmaceutical compositions containing them | |
| GB9518033D0 (en) | Composition | |
| IL117981A0 (en) | Compositions containing 2-oxetanones their preparation and use | |
| HUP9600352A2 (en) | Bitumenous composition | |
| PL322529A1 (en) | Complex compositions containing benazeoprile or benazeprilate and valsartan | |
| HUP9802997A3 (en) | Antisudorific and/or deodorant compositions | |
| PL331423A1 (en) | Muporocin and chlorohexidrin containing compositions | |
| IL116015A0 (en) | Iminooxymethyleneanilides thdir preparation and compositions containing them | |
| IL112564A0 (en) | 1-beta-methyl-carbapenems and compositions containing them | |
| HU9402155D0 (en) | Azin-derivatives and insekticidal composition containing them | |
| IL113542A0 (en) | Substituted hydroxybenzyl-heteroaryl derivatives compositions containing them and their use | |
| GB9508323D0 (en) | Composition | |
| IL117618A0 (en) | Diphenylmethyl-azetidinone derivatives and pharmaceutical compositions containing the same | |
| GB9609515D0 (en) | Powder composition | |
| IL118547A0 (en) | Aqueous film-formimg compositions and their use | |
| IL117155A0 (en) | Quinolizinone derivatives and pharmaceutical compositions containing the same |